In colon cancer study, TAMs expressing PD-1 presented weakened phagocytic potency, associating with reduced survival (Gordon et al., 2017), while in early lung cancer study the PD-1+ TAMs did not affect tumor-specific T cell attack against tumor (Singhal et al., 2019). Here, PDCD1 is linked to colonic neoplasm.